Regulation of Toll-like receptor-mediated inflammatory response by microRNA-152-3p-mediated demethylation of MyD88 in systemic lupus erythematosus
- PMID: 33507312
- DOI: 10.1007/s00011-020-01433-y
Regulation of Toll-like receptor-mediated inflammatory response by microRNA-152-3p-mediated demethylation of MyD88 in systemic lupus erythematosus
Abstract
Objective: microRNAs (miRNAs) play critical roles in embryogenesis, cell differentiation and the pathogenesis of several human diseases, including systemic lupus erythematosus (SLE). Toll-like receptors (TLRs) are also known to exert crucial functions in the immune response activation occurring in the pathogenesis of autoimmune diseases like SLE. Herein, the current study aimed to explore the potential role of miR-152-3p in TLR-mediated inflammatory response in SLE.
Methods: We determined the miR-152-3p expression profiles in CD4+ T cells and peripheral blood mononuclear cells (PBMCs) harvested from patients with SLE and healthy controls, and analyzed the correlation between miR-152-3p expression and clinicopathological parameters. CD70 and CD40L expression patterns in CD4+ T cells were assessed by RT-qPCR and flow cytometry. ChIP was adopted to determine the enrichment of DNA methyltransferase 1 (DNMT1) in the promoter region of myeloid differentiation factor 88 (MyD88).
Results: The obtained findings revealed that miR-152-3p was highly-expressed in CD4+ T cells and PBMCs of patients with SLE, and this high expression was associated with facial erythema, joint pain, double-stranded DNA, and IgG antibody. DNMT1 could be enriched in the MyD88 promoter, and miR-152-3p inhibited the methylation of MyD88 by targeting DNMT1. We also found that silencing miR-152-3p inhibited MyD88 expression not only to repress the autoreactivity of CD4+ T cells and but also to restrain their cellular inflammation, which were also validated in vivo.
Conclusion: Our study suggests that miR-152-3p promotes TLR-mediated inflammatory response in CD4+ T cells by regulating the DNMT1/MyD88 signaling pathway, which highlights novel anti-inflammatory target for SLE treatment.
Keywords: CD4+ T cells; DNA methyltransferase 1; Inflammatory response; Myeloid differentiation primary response gene 88; Systemic lupus erythematosus; Toll-like receptor; microRNA-152-3p.
Similar articles
-
MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1.J Immunol. 2010 Jun 15;184(12):6773-81. doi: 10.4049/jimmunol.0904060. Epub 2010 May 17. J Immunol. 2010. PMID: 20483747
-
Inhibition of microRNA-448 suppresses CD4+ T cell inflammatory activation via up-regulating suppressor of cytokine signaling 5 in systemic lupus erythematosus.Biochem Biophys Res Commun. 2022 Mar 12;596:88-96. doi: 10.1016/j.bbrc.2022.01.097. Epub 2022 Jan 29. Biochem Biophys Res Commun. 2022. PMID: 35121374
-
Jieduquyuziyin prescription enhances CD11a and CD70 DNA methylation of CD4+ T cells via miR-29b-sp1/DNMT1 pathway in MRL/lpr mice.J Ethnopharmacol. 2023 Dec 5;317:116776. doi: 10.1016/j.jep.2023.116776. Epub 2023 Jun 19. J Ethnopharmacol. 2023. PMID: 37343653
-
Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.Immunol Invest. 2023 Apr;52(3):364-397. doi: 10.1080/08820139.2023.2168554. Epub 2023 Feb 6. Immunol Invest. 2023. PMID: 36745138 Review.
-
Regulation of B-cell function by miRNAs impacting Systemic lupus erythematosus progression.Gene. 2025 Jan 15;933:149011. doi: 10.1016/j.gene.2024.149011. Epub 2024 Oct 18. Gene. 2025. PMID: 39427831 Review.
Cited by
-
Epigenetic Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus.Int J Mol Sci. 2024 Jan 13;25(2):1019. doi: 10.3390/ijms25021019. Int J Mol Sci. 2024. PMID: 38256093 Free PMC article. Review.
-
Targeting of EIF4EBP1 by miR-99a-3p affects the functions of B lymphocytes via autophagy and aggravates SLE disease progression.J Cell Mol Med. 2021 Nov;25(21):10291-10305. doi: 10.1111/jcmm.16991. Epub 2021 Oct 20. J Cell Mol Med. 2021. PMID: 34668631 Free PMC article.
-
Advances in the study of exosome-derived miRNAs in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus.Lupus. 2023 Nov;32(13):1475-1485. doi: 10.1177/09612033231212280. Epub 2023 Oct 31. Lupus. 2023. PMID: 37906972 Free PMC article. Review.
-
An updated review on abnormal epigenetic modifications in the pathogenesis of systemic lupus erythematosus.Front Immunol. 2025 Jan 6;15:1501783. doi: 10.3389/fimmu.2024.1501783. eCollection 2024. Front Immunol. 2025. PMID: 39835138 Free PMC article. Review.
-
[Qihuang Jianpi Zishen Granules ameliorate renal damage in MRL/lpr mice by inhibiting the MyD88/NF-κB pathway].Nan Fang Yi Ke Da Xue Xue Bao. 2025 Aug 20;45(8):1625-1632. doi: 10.12122/j.issn.1673-4254.2025.08.07. Nan Fang Yi Ke Da Xue Xue Bao. 2025. PMID: 40916524 Free PMC article. Chinese.
References
-
- Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2019. https://doi.org/10.1007/s12519-019-00229-3 . - DOI - PubMed - PMC
-
- Becker LV, Passos DF, Leal DBR, Morsch VM, Schetinger MRC. ATP signaling and NTPDase in systemic lupus erythematosus (SLE). Immunobiology. 2019;224:419–26. - DOI
-
- Yin ZJ, Ju BM, Zhu L, Hu N, Luo J, He M, Feng XY, Lv XH, Pu D, He L. Increased CD4(+)CD25(−)Foxp3(+) T cells in Chinese systemic lupus erythematosus: correlate with disease activity and organ involvement. Lupus. 2018;27:2057–68. - DOI
-
- Quiroz EN, Quiroz RN, Lugo LP, Martinez GA, Escorcia LG, Torres HG, Bonfanti AC, Marmolejo MDC, Sanchez E, Camacho JLV, Lorenzi H, Torres A, Navarro KF, Rodriguez PN, Villa JL, Fernandez-Ponce C. Integrated analysis of microRNA regulation and its interaction with mechanisms of epigenetic regulation in the etiology of systemic lupus erythematosus. PLoS ONE. 2019;14:e0218116. - DOI
-
- Su X, Ye L, Chen X, Zhang H, Zhou Y, Ding X, Chen D, Lin Q, Chen C. MiR-199-3p promotes ERK-mediated IL-10 production by targeting poly (ADP-ribose) polymerase-1 in patients with systemic lupus erythematosus. Chem Biol Interact. 2019;306:110–6. - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials